5 September 2024
Latham Advises Platinum Equity on Acquisition of Inventia Healthcare
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Sidharth Bhasin Lead | Latham & Watkins LLP | Partner | corporate | Singapore |
| Michael Rackham | Latham & Watkins LLP | Counsel | Not stated | Not stated |
| Mark Hu | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Elisabeth Ong | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Cherine Teh | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Benjamin Han | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Zoe Wang | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Christopher Schott | Latham & Watkins LLP | Partner | healthcare | Washington, D.C. |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | healthcare | Paris |
| Oliver Mobasser | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Jeanne Fabre | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Elisabeth Crusey | Latham & Watkins LLP | Associate | healthcare | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Platinum EquityBuy-side
- Counterparties
- Inventia Healthcare (Target)